Free fatty acids enhance breast cancer cell migration through plasminogen activator inhibitor-1 and SMAD4

被引:44
|
作者
Byon, Chang Hyun [2 ]
Hardy, Robert W. [1 ]
Ren, Changchun [1 ]
Ponnazhagan, Selvarangan [1 ]
Welch, Danny R. [1 ,2 ]
McDonald, Jay M. [1 ,3 ]
Chen, Yabing [1 ]
机构
[1] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA
[2] Univ Alabama Birmingham, Dept Cell Biol, Birmingham, AL 35294 USA
[3] Vet Adm Med Ctr, Birmingham, AL USA
关键词
free fatty acids; breast cancer cell; migration; PAI-1; SMAD4; IN-VITRO; LINOLEIC-ACID; GROWTH; GENE; OBESITY; EXPRESSION; INVASION; IDENTIFICATION; METASTASIS; OVERWEIGHT;
D O I
10.1038/labinvest.2009.97
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Obesity is a risk factor for breast cancer and is associated with increased plasma concentrations of free fatty acids (FFAs). We and others have demonstrated that FFA induces plasminogen activator inhibitor-1 (PAI-1) expression in a variety of cells. Emerging evidence supports elevation of PAI-1 as a prognostic marker for breast cancer. Therefore, we hypothesized that FFAs might increase expression of PAI-1 in breast cancer cells and facilitate breast cancer progression. Secreted PAI-1 was higher in invasive and metastatic MDA-MB-231 cells compared with less invasive and non-metastatic Hs578T cells. Utilizing FFAs with different saturation and chain lengths, we demonstrated that linoleic acid induced expression of PAI-1 in MDA-MB-231 cells. Linoleic acid also induced in vitro migration of MDA-MB-231. By contrast, other FFAs tested had little or no effect on PAI-1 expression or migration. Linoleic acid-induced breast cancer cell migration was completely inhibited by virally expressed antisense PAI-1 RNA. Furthermore, increased expression of PAI-1 by FFAs was not detected in the SMAD4-deficient MDA-MB-468 breast carcinoma cells. Electrophoretic mobility-shift assay confirmed that linoleic acid-induced expression of PAI-1 was mediated, at least in part, by SMAD4 in MDA-MB-231 cells. That linoleic acid induces PAI-1 expression in breast cancer cells through SMAD4 provides a novel insight into understanding the relationships between two migration-associated molecules, FFAs, and PAI-1. Laboratory Investigation (2009) 89, 1221-1228; doi: 10.1038/labinvest.2009.97; published online 14 September 2009
引用
收藏
页码:1221 / 1228
页数:8
相关论文
共 50 条
  • [31] Plasminogen activator inhibitor-1 and tenascin-C secreted by equine mesenchymal stromal cells stimulate dermal fibroblast migration in vitro and contribute to wound healing in vivo
    Harman, Rebecca M.
    He, Megan K.
    Zhang, Sheng
    Van de Walle, Gerlinde R.
    CYTOTHERAPY, 2018, 20 (08) : 1061 - 1076
  • [32] Plasminogen activator inhibitor-1 (PAI-1) gene 4G/5G promoter polymorphism is not associated with breast cancer
    Blasiak, J
    Smolarz, B
    ACTA BIOCHIMICA POLONICA, 2000, 47 (01) : 191 - 199
  • [33] Saturated Fatty Acid Intake Can Influence Increase in Plasminogen Activator Inhibitor-1 in Obese Adolescents
    Masquio, D. C. L.
    de Piano, A.
    Campos, R. M. S.
    Sanches, P. L.
    Corgosinho, F. C.
    Carnier, J.
    Oyama, L. M.
    do Nascimento, C. M. P. O.
    de Mello, M. T.
    Tufik, S.
    Damaso, A. R.
    HORMONE AND METABOLIC RESEARCH, 2014, 46 (04) : 245 - 251
  • [34] (-)-Epigallocatechin gallate derivatives reduce the expression of both urokinase plasminogen activator and plasminogen activator inhibitor-1 to inhibit migration, adhesion, and invasion of MDA-MB-231 cells
    Shin, Sunhye
    Kim, Mi Kyoung
    Jung, Woong
    Chong, Youhoon
    PHYTOTHERAPY RESEARCH, 2018, 32 (10) : 2086 - 2096
  • [35] Urokinase Plasminogen Activator Receptor (uPAR) and Plasminogen Activator Inhibitor-1 (PAI-1) Are Potential Predictive Biomarkers in Early Stage Oral Squamous Cell Carcinomas (OSCC)
    Magnussen, Synnove
    Rikardsen, Oddveig G.
    Hadler-Olsen, Elin
    Uhlin-Hansen, Lars
    Steigen, Sonja E.
    Svineng, Gunbjorg
    PLOS ONE, 2014, 9 (07):
  • [36] Overexpression of Plasminogen Activator Inhibitor-1 in Advanced Gastric Cancer with Aggressive Lymph Node Metastasis
    Suh, Yun-Suhk
    Yu, Jieun
    Kim, Byung Chul
    Choi, Boram
    Han, Tae-Su
    Ahn, Hye Seong
    Kong, Seong-Ho
    Lee, Hyuk-Joon
    Kim, Woo Ho
    Yang, Han-Kwang
    CANCER RESEARCH AND TREATMENT, 2015, 47 (04): : 718 - 726
  • [37] Role of plasminogen activator inhibitor and free fatty acids in diagnosis of insulin resistance in patients with myocardial infarction
    Gruzdeva, O., V
    Barbarash, O. L.
    Akbasheva, O. E.
    Fedorova, T. S.
    Palicheva, E., I
    Kashtalap, V. V.
    Dyleva, Y. A.
    Silonova, A. A.
    Sionina, E., V
    Uchasova, E. G.
    DIABETES MELLITUS, 2011, 14 (04): : 18 - 23
  • [38] TIF1γ and SMAD4 regulation in colorectal cancer: impact on cell proliferation and liver metastasis
    Wu, Yanhui
    Yu, Bin
    Ai, Xi
    Zhang, Wei
    Chen, Weixun
    Laurence, Arian
    Zhang, Mingzhi
    Chen, Qian
    Shao, Yajie
    Zhang, Bixiang
    BIOLOGICAL CHEMISTRY, 2024, 405 (04) : 241 - 256
  • [39] Association between plasminogen activator inhibitor-1 in young adulthood and nonalcoholic fatty liver disease in midlife: CARDIA
    Campbell, Patrick T.
    VanWagner, Lisa B.
    Colangelo, Laura A.
    Lewis, Cora E.
    Henkel, Anne
    Ajmera, Veeral H.
    Lloyd-Jones, Donald M.
    Vaughan, Douglas E.
    Khan, Sadiya S.
    LIVER INTERNATIONAL, 2020, 40 (05) : 1111 - 1120
  • [40] TAp73 Inhibits EMT and Cell Migration in Pancreatic Cancer Cells through Promoting SMAD4 Expression and SMAD4-Dependent Inhibition of ERK Activation
    Ungefroren, Hendrik
    Konukiewitz, Bjorn
    Braun, Rudiger
    Wellner, Ulrich Friedrich
    Lehnert, Hendrik
    Marquardt, Jens-Uwe
    CANCERS, 2023, 15 (15)